head and neck cancer
CEL-SCI’s Phase III Trial Enrols Patients From Sri Lanka
CEL-SCI has begun enrolling patients from Sri Lanka for a Phase III trial for Multikine, an investigational treatment for head and neck cancer.
Soligenix, SciClone To Collaborate On Oral Mucositis Drug For Chinese Market
Soligenix, Inc. will collaborate with SciClone Pharmaceuticals in China on its oral mucositis drug candidate, SGX942.
CEL-SCI Starts Ph III Trials For Head And Neck Cancer In Taiwan
CEL-SCI has initiated Phase III clinical trials in Taiwan for its head and neck cancer immunotherapy drug.
